Petmed Express PETS
Petmed Express reported Q2 2027 results
Petmed Express (PETS) filed an 8-K with the SEC on Nov 10, 2026, 4:18 pm ET. Source: the filing on SEC EDGAR.
Item 2.02 Reports results
- Form
- 8-K
- Filed
- Importance
- Major
- Accession
- 0001040130-26-000068
- Net sales were $35.8 million, down 19.4% from $44.4 million
- Net loss was $6.4 million, or $0.31 per share, compared to $8.5 million, or $0.41 per share
- Adjusted EBITDA was $(3.6) million, compared to $(2.3) million
Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.
